Kalitin, N.; Koroleva, N.; Lushnikova, A.; Babaeva, M.; Samoylenkova, N.; Savchenko, E.; Smirnova, G.; Borisova, Y.; Kostarev, A.; Karamysheva, A.;
et al. N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction. Pharmaceuticals 2024, 17, 1642.
https://doi.org/10.3390/ph17121642
AMA Style
Kalitin N, Koroleva N, Lushnikova A, Babaeva M, Samoylenkova N, Savchenko E, Smirnova G, Borisova Y, Kostarev A, Karamysheva A,
et al. N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction. Pharmaceuticals. 2024; 17(12):1642.
https://doi.org/10.3390/ph17121642
Chicago/Turabian Style
Kalitin, Nikolay, Natalia Koroleva, Anna Lushnikova, Maria Babaeva, Nadezhda Samoylenkova, Ekaterina Savchenko, Galina Smirnova, Yulia Borisova, Alexander Kostarev, Aida Karamysheva,
and et al. 2024. "N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction" Pharmaceuticals 17, no. 12: 1642.
https://doi.org/10.3390/ph17121642
APA Style
Kalitin, N., Koroleva, N., Lushnikova, A., Babaeva, M., Samoylenkova, N., Savchenko, E., Smirnova, G., Borisova, Y., Kostarev, A., Karamysheva, A., & Pavlova, G.
(2024). N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction. Pharmaceuticals, 17(12), 1642.
https://doi.org/10.3390/ph17121642
